9-2110275-G-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The NM_003070.5(SMARCA2):c.3314G>A(p.Arg1105His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1105C) has been classified as Pathogenic.
Frequency
Consequence
NM_003070.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA2 | NM_003070.5 | c.3314G>A | p.Arg1105His | missense_variant | 24/34 | ENST00000349721.8 | NP_003061.3 | |
SMARCA2 | NM_001289396.1 | c.3314G>A | p.Arg1105His | missense_variant | 24/34 | NP_001276325.1 | ||
SMARCA2 | NM_139045.4 | c.3314G>A | p.Arg1105His | missense_variant | 24/33 | NP_620614.2 | ||
SMARCA2 | NM_001289397.2 | c.3140G>A | p.Arg1047His | missense_variant | 24/33 | NP_001276326.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA2 | ENST00000349721.8 | c.3314G>A | p.Arg1105His | missense_variant | 24/34 | 5 | NM_003070.5 | ENSP00000265773.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Nicolaides-Baraitser syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 01, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Sep 02, 2020 | This variant was identified as de novo (maternity and paternity confirmed). - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2024 | The p.R1105H pathogenic mutation (also known as c.3314G>A) is located in exon 24 (coding exon 23) of the SMARCA2 gene. This alteration results from a G to A substitution at nucleotide position 3314, causing the arginine (R) at amino acid position 1105 to be replaced by a histidine (H). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This variant was reported in multiple individuals with features consistent with SMARCA2-related neurodevelopmental disorder; in at least one instance, this variant has been determined to be the result of a de novo mutation (Santen, 2013; Vissers, 2017; Henriquez-Lopez, 2023; Ambry internal data). Other alterations at the same codon, c.3313C>T (p.R1105C) and c.3314G>C (p.R1105P), have been reported in individuals with features consistent with SMARCA2-related neurodevelopmental disorder (Van Houdt, 2012). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis and located in a region that has a low rate of benign missense variation (Lek, 2016; Firth, 2009). Based on the supporting evidence, this variant is interpreted as a disease-causing mutation. - |
Blepharophimosis-impaired intellectual development syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 01, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at